Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine.

Christina A MetcalfChloe E PageBrianna O S StockerRachel L JohnsonKorrina A DuffyMary D SammelJames LougheadC Neill Epperson

Published in: Gynecologic oncology (2024)

Lisdexamfetamine improved both subjective and objective measures of attention and working memory and could offer women experiencing cognitive difficulties post-risk-reducing salpingo-oophorectomy an alternative therapeutic option.

Keyphrases

working memory
breast cancer risk
transcranial direct current stimulation
attention deficit hyperactivity disorder
replacement therapy
clinical trial
study protocol
adipose tissue
type diabetes
skeletal muscle
sleep quality